Differences in clinicopathological characteristics between lipohypertrophy and localized insulin‐derived amyloidosis: A scoping review

Abstract Insulin is used as a therapeutic agent in patients with diabetes, and cutaneous lipohypertrophy (LH) and localized insulin‐derived amyloidosis (LIDA) are well‐known adverse effects associated with insulin injections. The clinical implications, management, assessment methods, and pathologica...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Kanae Mukai, Hiromasa Tanno, Junko Sugama, Toshihiko Yanagita, Emi Kanno
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2024-03-01
Schriftenreihe:	Chronic Diseases and Translational Medicine
Schlagworte:	diabetes mellitus insulin injection lipohypertrophy localized insulin‐derived amyloidosis
Online-Zugang:	https://doi.org/10.1002/cdt3.98
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!